國立虎尾科技大學 |

Emerging Transplant Infections = Clinical Challenges and Implications /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Emerging Transplant Infections/ edited by Michele I. Morris, Camille Nelson Kotton, Cameron R. Wolfe.
其他題名:	Clinical Challenges and Implications /
其他作者:	Wolfe, Cameron R.
面頁冊數:	132 illus., 26 illus. in color. eReference.online resource. :
Contained By:	Springer Nature eReference
標題:	Public Health. -
電子資源:	https://doi.org/10.1007/978-3-030-25869-6
ISBN:	9783030258696

Emerging Transplant Infections = Clinical Challenges and Implications /
Emerging Transplant InfectionsClinical Challenges and Implications /[electronic resource] :edited by Michele I. Morris, Camille Nelson Kotton, Cameron R. Wolfe. - 1st ed. 2021. - 132 illus., 26 illus. in color. eReference.online resource.

Infectious Diseases – impact of infections on transplant morbidity/mortality, data on ID impact on outcomes, and important role of Infectious Disease providers in the transplant team -- Intro to Solid Organ Transplant -- Intro to Stem Cell Transplantation -- General concepts -- Hospital epi / InfControl issues -- Antibiotic Stewardship for transplant ID -- Prophylaxis in the era of emerging new infectious pathogens -- Pre-transplant evaluation of patients with MDRO infection/colonization -- Pre-transplant screening of patients with epidemiologic & geographic risk factors for infection exposure -- Safe living post-transplant -- Vaccination -- Travel medicine and the Transplant Recipient – Infection Avoidance & Management of the Returning Traveler with Fever including Transplant Tourism -- Changing definition of Immunosuppression – Biologics, Monoclonal Antibodies – what infections will emerge as a result and how do we prevent them? -- Multidrug Resistant Organisms including Extended Spectrum Beta Lactamase Producing Organisms & Carbapenemase Resistant Enterobacteriaceae -- Mycobacterium tuberculosis -- Rapidly Growing Nontuberculous Mycobacteria -- Slow Growing Nontuberculous Mycobacteria -- Nocardia -- Mycoplasma / Ureaplasma -- Pseudomonas including Pseudomonas pseudomallei -- Acinetobacter -- Burkholderia -- Clostridia Difficile -- Cytomegalovirus -- Herpes Simplex -- Varicella Zoster -- Epstein Barr Virus including PTLD -- HHV6, HHV7, HHV8 -- BK Virus -- Influenza -- Respiratory Syncytial Virus -- Respiratory viruses including parainfluenza, metapneumovirus, rhinovirus, enterovirus, coronaviruses (MERS CoV & SARS) -- Adenovirus -- HIV -- Hepatitis A & E -- Hepatitis B & D -- Hepatitis C -- West Nile Virus -- Dengue, Chikungunya, & Zika -- Yellow Fever -- Viral Encephalitides including Rabies & Lymphocytic Choriomeningitis Virus -- Candida -- Aspergillus -- Mucorales -- Non-Aspergillus Molds esp. Phaeohyphomycoses -- Cryptococcus including gatti -- Pneumocystis -- Endemic molds – coccidioidomycosis, histoplasmosis, blastomycosis, paracoccidioidomycosis -- Toxoplasmosis -- Strongyloidiasis -- Chagas disease -- Leishmaniasis -- Malaria -- Entamoeba histolytica -- Intestinal Parasites including Cryptosporidium, Cyclospora, Microsporidia, Blastocystis hominis, Isospora, Giardia -- Acanthamoeba, Naegleria, & Balamuthia -- Ventricular Assist Devices/ECMO/Cardiac Support -- Infection in Vascular Composite Allografts -- Rash -- Eye infections -- Pulmonary -- Diarrhea -- Encephalitis & Delerium -- Cytopenias including Anemia and Neutropenic Fever.

The field of transplant medicine has evolved significantly since the first kidney transplant was performed in 1954. Innovations in transplant immunosuppression have lowered the risk of organ rejection so that infectious complications are now the leading cause of hospitalization and mortality after solid organ transplant. Infection is also cited as the leading cause of non-relapse mortality after stem cell transplantation. As transplant centers have recognized the importance of transplant specific expertise in patient outcomes, the field of transplant infectious diseases has expanded into a recognized and highly valued subspecialty. International growth in solid organ and stem cell transplantation has outpaced access to such expertise, with some centers employing microbiology laboratory directors and transplant nephrologists as their lead infectious diseases consultants. This has been a particular challenge as the use of novel immunosuppressive regimens in new geographic and immigrant populations have fueled the emergence of new infection syndromes, with the initial presentation sometimes occurring in this most vulnerable patient population. This digital-first book is designed to meet the needs of practitioners engaged in transplant infectious disease practice who need more depth than they are able to find in UpToDate. It provides an overview of emerging infectious disease challenges with clinically relevant information regarding the epidemiology, diagnosis, management, and prevention of infections in solid organ and stem cell transplant recipients. Each chapter focuses on a clinical syndrome or pathogen with new or emerging implications for transplant patients. Given the rapidly evolving nature of emerging infections and topics in transplant infections, no resource has been published on these increasingly notorious issues; this this text is written by top, global experts who regularly update the material to ensure that readers will always have access to the most cutting edge material available. The editorial team consists of three experienced leaders in the field, all of whom have a strong record of scholarship and publication, as well as an international reputation. All three have focused their academic careers on emerging infectious diseases in transplantation, including a current and a past president of various infectious diseases and transplantation societies. The editors are also experienced reviewers and authors who have collaborated on multiple previous projects. All are committed to this project as a unique opportunity to make an important contribution to their field.

ISBN: 9783030258696

Standard No.: 10.1007/978-3-030-25869-6doiSubjects--Topical Terms:

592982
Public Health.

LC Class. No.: RC109-216

Dewey Class. No.: 616.9

Emerging Transplant Infections = Clinical Challenges and Implications /
LDR:06535nam a22003735i 4500 001 1055757
003 DE-He213
005 20210812025632.0
007 cr nn 008mamaa
008 220103s2021 sz | s |||| 0|eng d
020 $a 9783030258696 $9 978-3-030-25869-6
024 7 $a 10.1007/978-3-030-25869-6 $2 doi
035 $a 978-3-030-25869-6
050 4 $a RC109-216
072 7 $a MJCJ $2 bicssc
072 7 $a MED022090 $2 bisacsh
072 7 $a MJCJ $2 thema
082 0 4 $a 616.9 $2 23
245 1 0 $a Emerging Transplant Infections $h [electronic resource] : $b Clinical Challenges and Implications / $c edited by Michele I. Morris, Camille Nelson Kotton, Cameron R. Wolfe.
250 $a 1st ed. 2021.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a 132 illus., 26 illus. in color. eReference. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Infectious Diseases – impact of infections on transplant morbidity/mortality, data on ID impact on outcomes, and important role of Infectious Disease providers in the transplant team -- Intro to Solid Organ Transplant -- Intro to Stem Cell Transplantation -- General concepts -- Hospital epi / InfControl issues -- Antibiotic Stewardship for transplant ID -- Prophylaxis in the era of emerging new infectious pathogens -- Pre-transplant evaluation of patients with MDRO infection/colonization -- Pre-transplant screening of patients with epidemiologic & geographic risk factors for infection exposure -- Safe living post-transplant -- Vaccination -- Travel medicine and the Transplant Recipient – Infection Avoidance & Management of the Returning Traveler with Fever including Transplant Tourism -- Changing definition of Immunosuppression – Biologics, Monoclonal Antibodies – what infections will emerge as a result and how do we prevent them? -- Multidrug Resistant Organisms including Extended Spectrum Beta Lactamase Producing Organisms & Carbapenemase Resistant Enterobacteriaceae -- Mycobacterium tuberculosis -- Rapidly Growing Nontuberculous Mycobacteria -- Slow Growing Nontuberculous Mycobacteria -- Nocardia -- Mycoplasma / Ureaplasma -- Pseudomonas including Pseudomonas pseudomallei -- Acinetobacter -- Burkholderia -- Clostridia Difficile -- Cytomegalovirus -- Herpes Simplex -- Varicella Zoster -- Epstein Barr Virus including PTLD -- HHV6, HHV7, HHV8 -- BK Virus -- Influenza -- Respiratory Syncytial Virus -- Respiratory viruses including parainfluenza, metapneumovirus, rhinovirus, enterovirus, coronaviruses (MERS CoV & SARS) -- Adenovirus -- HIV -- Hepatitis A & E -- Hepatitis B & D -- Hepatitis C -- West Nile Virus -- Dengue, Chikungunya, & Zika -- Yellow Fever -- Viral Encephalitides including Rabies & Lymphocytic Choriomeningitis Virus -- Candida -- Aspergillus -- Mucorales -- Non-Aspergillus Molds esp. Phaeohyphomycoses -- Cryptococcus including gatti -- Pneumocystis -- Endemic molds – coccidioidomycosis, histoplasmosis, blastomycosis, paracoccidioidomycosis -- Toxoplasmosis -- Strongyloidiasis -- Chagas disease -- Leishmaniasis -- Malaria -- Entamoeba histolytica -- Intestinal Parasites including Cryptosporidium, Cyclospora, Microsporidia, Blastocystis hominis, Isospora, Giardia -- Acanthamoeba, Naegleria, & Balamuthia -- Ventricular Assist Devices/ECMO/Cardiac Support -- Infection in Vascular Composite Allografts -- Rash -- Eye infections -- Pulmonary -- Diarrhea -- Encephalitis & Delerium -- Cytopenias including Anemia and Neutropenic Fever.
520 $a The field of transplant medicine has evolved significantly since the first kidney transplant was performed in 1954. Innovations in transplant immunosuppression have lowered the risk of organ rejection so that infectious complications are now the leading cause of hospitalization and mortality after solid organ transplant. Infection is also cited as the leading cause of non-relapse mortality after stem cell transplantation. As transplant centers have recognized the importance of transplant specific expertise in patient outcomes, the field of transplant infectious diseases has expanded into a recognized and highly valued subspecialty. International growth in solid organ and stem cell transplantation has outpaced access to such expertise, with some centers employing microbiology laboratory directors and transplant nephrologists as their lead infectious diseases consultants. This has been a particular challenge as the use of novel immunosuppressive regimens in new geographic and immigrant populations have fueled the emergence of new infection syndromes, with the initial presentation sometimes occurring in this most vulnerable patient population. This digital-first book is designed to meet the needs of practitioners engaged in transplant infectious disease practice who need more depth than they are able to find in UpToDate. It provides an overview of emerging infectious disease challenges with clinically relevant information regarding the epidemiology, diagnosis, management, and prevention of infections in solid organ and stem cell transplant recipients. Each chapter focuses on a clinical syndrome or pathogen with new or emerging implications for transplant patients. Given the rapidly evolving nature of emerging infections and topics in transplant infections, no resource has been published on these increasingly notorious issues; this this text is written by top, global experts who regularly update the material to ensure that readers will always have access to the most cutting edge material available. The editorial team consists of three experienced leaders in the field, all of whom have a strong record of scholarship and publication, as well as an international reputation. All three have focused their academic careers on emerging infectious diseases in transplantation, including a current and a past president of various infectious diseases and transplantation societies. The editors are also experienced reviewers and authors who have collaborated on multiple previous projects. All are committed to this project as a unique opportunity to make an important contribution to their field.
650 2 4 $a Public Health. $3 592982
650 2 4 $a Tropical Medicine. $3 668883
650 2 4 $a Oncology. $3 593951
650 2 4 $a Emergency Medicine. $3 644340
650 1 4 $a Infectious Diseases. $3 668393
650 0 $a Public health. $3 560998
650 0 $a Tropical medicine. $3 673736
650 0 $a Oncology . $3 1253469
650 0 $a Emergency medicine. $3 644138
650 0 $a Hematology. $3 645254
650 0 $a Infectious diseases. $3 1102043
700 1 $a Wolfe, Cameron R. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1361012
700 1 $a Kotton, Camille Nelson. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1314393
700 1 $a Morris, Michele I. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1314392
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eReference
776 0 8 $i Printed edition: $z 9783030258689
856 4 0 $u https://doi.org/10.1007/978-3-030-25869-6
912 $a ZDB-2-SME
912 $a ZDB-2-SXRM
950 $a Medicine (SpringerNature-11650)
950 $a Reference Module Medicine (SpringerNature-43750)